Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Modular peptide recognition domains in eukaryotic signaling.

Kuriyan J, Cowburn D.

Annu Rev Biophys Biomol Struct. 1997;26:259-88. Review.

PMID:
9241420
2.

Structure of the regulatory domains of the Src-family tyrosine kinase Lck.

Eck MJ, Atwell SK, Shoelson SE, Harrison SC.

Nature. 1994 Apr 21;368(6473):764-9.

PMID:
7512222
3.

Tyrosine kinase signalling pathways.

Pawson T.

Princess Takamatsu Symp. 1994;24:303-22. Review.

PMID:
8983084
4.

Domain interactions in protein tyrosine kinase Csk.

Sondhi D, Cole PA.

Biochemistry. 1999 Aug 24;38(34):11147-55.

PMID:
10460171
5.

SH2 and PTB domains in tyrosine kinase signaling.

Schlessinger J, Lemmon MA.

Sci STKE. 2003 Jul 15;2003(191):RE12. Review.

PMID:
12865499
6.

The role of the Src homology 3-Src homology 2 interface in the regulation of Src kinases.

Arold ST, Ulmer TS, Mulhern TD, Werner JM, Ladbury JE, Campbell ID, Noble ME.

J Biol Chem. 2001 May 18;276(20):17199-205. Epub 2001 Feb 2.

7.

The 1.1 A resolution crystal structure of the p130cas SH3 domain and ramifications for ligand selectivity.

Wisniewska M, Bossenmaier B, Georges G, Hesse F, Dangl M, Künkele KP, Ioannidis I, Huber R, Engh RA.

J Mol Biol. 2005 Apr 15;347(5):1005-14.

PMID:
15784259
8.

L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.

Ye B, Akamatsu M, Shoelson SE, Wolf G, Giorgetti-Peraldi S, Yan X, Roller PP, Burke TR Jr.

J Med Chem. 1995 Oct 13;38(21):4270-5.

PMID:
7473554
9.

Phage display selection of ligand residues important for Src homology 3 domain binding specificity.

Rickles RJ, Botfield MC, Zhou XM, Henry PA, Brugge JS, Zoller MJ.

Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):10909-13.

10.

PTB domain-directed substrate targeting in a tyrosine kinase from the unicellular choanoflagellate Monosiga brevicollis.

Prieto-Echagüe V, Chan PM, Craddock BP, Manser E, Miller WT.

PLoS One. 2011 Apr 26;6(4):e19296. doi: 10.1371/journal.pone.0019296.

11.
12.

Promiscuous binding nature of SH3 domains to their target proteins.

Agrawal V, Kishan KV.

Protein Pept Lett. 2002 Jun;9(3):185-93. Review.

PMID:
12144515
13.

Crystal structure of the Src family tyrosine kinase Hck.

Sicheri F, Moarefi I, Kuriyan J.

Nature. 1997 Feb 13;385(6617):602-9.

PMID:
9024658
14.

SH2/SH3 signaling proteins.

Schlessinger J.

Curr Opin Genet Dev. 1994 Feb;4(1):25-30. Review.

PMID:
8193536
15.

Crystal structure and NMR studies of the apo SH2 domains of ZAP-70: two bikes rather than a tandem.

Folmer RH, Geschwindner S, Xue Y.

Biochemistry. 2002 Dec 3;41(48):14176-84.

PMID:
12450381
16.

Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors.

Burke TR Jr, Yao ZJ, Liu DG, Voigt J, Gao Y.

Biopolymers. 2001;60(1):32-44. Review.

PMID:
11376431
17.

Src homology-2 domains: structure, mechanisms, and drug discovery.

Sawyer TK.

Biopolymers. 1998;47(3):243-61. Review.

PMID:
9817027
18.

A specific intermolecular association between the regulatory domains of a Tec family kinase.

Brazin KN, Fulton DB, Andreotti AH.

J Mol Biol. 2000 Sep 22;302(3):607-23.

PMID:
10986122
19.

Energetics of Src homology domain interactions in receptor tyrosine kinase-mediated signaling.

Ladbury JE, Arold ST.

Methods Enzymol. 2011;488:147-83. doi: 10.1016/B978-0-12-381268-1.00007-0.

PMID:
21195228
20.

SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins.

Koch CA, Anderson D, Moran MF, Ellis C, Pawson T.

Science. 1991 May 3;252(5006):668-74.

PMID:
1708916

Supplemental Content

Support Center